Latest HCV Stories
Presented: Monday, November 10, 2014, 3:00 pm Eastern - Hynes Convention Center, Boston, MA BOSTON, Nov.
Presented: Monday, November 10, 2014 - Hynes Convention Center, Boston, MA BOSTON, Nov.
Despite a Higher Price, Surveyed MCOs Have Prioritized Sovaldi Over Olysio for Formulary Inclusion and Preferred Drug Lists, According to Findings from Decision Resources Group BURLINGTON,
- Interim Results from Ongoing Study Demonstrate Human Proof-of-Concept and Underscore the Value of Regulus' microRNA Platform - LA JOLLA, Calif., Oct.
Data from 25 accepted abstracts include results from: NORTH CHICAGO, Ill., Oct.
MarketOptimizer.org adds “PharmaPoint: Hepatitis C Virus – Global Drug Forecast and Market Analysis to 2022 – Event-Driven Update” to its store.
NEW YORK, Sept.
Reimbursement and Out-of-Pocket Costs are the Leading Reasons for Treatment Discontinuation, According to Findings from Decision Resources Group BURLINGTON, Mass., Aug.
Doctor Evidence, LLC has developed a comprehensive database of clinical evidence in Hepatitis C (HCV) to address the evolving needs of healthcare stakeholders. Santa
Frost & Sullivan: The market is looking for a reasonably priced and convenient alternative to Gilead's blockbuster Sovaldi MOUNTAIN VIEW, Calif., July 29, 2014 /PRNewswire/ -- Drug development
Hepatitis C virus (HCV) is an enveloped, positive-sense single-stranded RNA virus of the family Flaviviridae. It consists of a core of genetic material surrounded by an icosahedra protective shell of protein. The genome consists of a single open reading frame that is 9600 nucleotide bases long. HCV replication takes several steps. It primarily replicates in the hepatocytes of the liver. It can also reproduce in peripheral blood mononuclear cells. There is a wide variety of genotypes and...
- A person or thing gazed at with wonder or curiosity, especially of a scornful kind.